Objective
Methods
A retrospective, observational cohort dataset from Waikato Hospital (New Zealand) was analysed, including 2 366 symptomatic patients with PAD who underwent revascularisation between 2010 and 2021. Clinical, biological, and procedural information, and outcomes (amputations and deaths) were acquired. The study investigated non-competing risk models (CPH, conditional survival forest, random survival forest, and non-linear CPH [NLCH]) and competing risk models (Fine and Gray subdistribution hazard model and DeepHit model). Models were developed using fivefold cross validation (80/20 training–validation split) stratified by median time to amputation. Performances were evaluated using the concordance index and integrated Brier score.